CUFinder

Olav Dalgard

About Olav Dalgard

Olav Dalgard, With an exceptional h-index of 41 and a recent h-index of 30 (since 2020), a distinguished researcher at Universitetet i Oslo, specializes in the field of Viral hepatitis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): a stepped wedge cluster randomized trial

Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli

Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China

Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study

Olav Dalgard Information

University

Position

Professor of medicine

Citations(all)

11850

Citations(since 2020)

7346

Cited By

6849

hIndex(all)

41

hIndex(since 2020)

30

i10Index(all)

78

i10Index(since 2020)

53

Email

University Profile Page

Google Scholar

Olav Dalgard Skills & Research Interests

Viral hepatitis

Top articles of Olav Dalgard

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature communications

2024/2/5

Cathrine Axfors
Cathrine Axfors

H-Index: 8

Perrine Janiaud
Perrine Janiaud

H-Index: 12

Sherief Abd-Elsalam
Sherief Abd-Elsalam

H-Index: 20

Derek C Angus
Derek C Angus

H-Index: 92

Olav Dalgard
Olav Dalgard

H-Index: 28

Lennie Derde
Lennie Derde

H-Index: 19

Yi-Chun Lin
Yi-Chun Lin

H-Index: 11

Ahmad Mourad
Ahmad Mourad

H-Index: 7

Susanna Naggie
Susanna Naggie

H-Index: 25

Muhammad Shahzad
Muhammad Shahzad

H-Index: 3

Shaimaa Soliman
Shaimaa Soliman

H-Index: 7

Nicholas A Turner
Nicholas A Turner

H-Index: 9

Maria Velinova
Maria Velinova

H-Index: 3

David Moher
David Moher

H-Index: 118

Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): a stepped wedge cluster randomized trial

Clinical Infectious Diseases

2024/3/15

Inge Christoffer Olsen
Inge Christoffer Olsen

H-Index: 25

Olav Dalgard
Olav Dalgard

H-Index: 28

Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli

Infectious Diseases

2024/1/2

Olav Dalgard
Olav Dalgard

H-Index: 28

Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China

Journal of Infection

2024/3/1

Yanling Ma
Yanling Ma

H-Index: 12

Jie Dai
Jie Dai

H-Index: 2

Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs

International Journal of Drug Policy

2024/1/1

Olav Dalgard
Olav Dalgard

H-Index: 28

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Journal of Infection

2024/3/1

Olav Dalgard
Olav Dalgard

H-Index: 28

Anastasia Kotanidou
Anastasia Kotanidou

H-Index: 29

Susana Silva
Susana Silva

H-Index: 17

Anna Piekarska
Anna Piekarska

H-Index: 3

Sotirios Tsiodras
Sotirios Tsiodras

H-Index: 35

Serhat Unal
Serhat Unal

H-Index: 31

Nathan Peiffer-Smadja
Nathan Peiffer-Smadja

H-Index: 13

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

2024/2/14

Jh Kao
Jh Kao

H-Index: 57

Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study

Substance Abuse Treatment, Prevention, and Policy

2024/3/26

Olav Dalgard
Olav Dalgard

H-Index: 28

Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection

International Journal of Drug Policy

2023/1/1

Olav Dalgard
Olav Dalgard

H-Index: 28

Martin Schaefer
Martin Schaefer

H-Index: 3

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

The Lancet Gastroenterology & Hepatology

2023/10/1

Thomas Berg
Thomas Berg

H-Index: 5

Young-Suk Lim
Young-Suk Lim

H-Index: 48

Soo Aleman
Soo Aleman

H-Index: 20

Hugo Cheinquer
Hugo Cheinquer

H-Index: 17

Kent Jason Cheng
Kent Jason Cheng

H-Index: 3

Fernando Contreras
Fernando Contreras

H-Index: 1

Chris Cunningham
Chris Cunningham

H-Index: 7

Olav Dalgard
Olav Dalgard

H-Index: 28

Robert De Knegt
Robert De Knegt

H-Index: 16

Paulo Ferreira
Paulo Ferreira

H-Index: 22

Irsan Hasan
Irsan Hasan

H-Index: 13

Angelos Hatzakis
Angelos Hatzakis

H-Index: 39

Javier Hernandez
Javier Hernandez

H-Index: 2

Jerzy Jaroszewicz
Jerzy Jaroszewicz

H-Index: 3

Aamir Khan
Aamir Khan

H-Index: 5

Martin Lagging
Martin Lagging

H-Index: 21

Pietro Lampertico
Pietro Lampertico

H-Index: 36

Alice Lee
Alice Lee

H-Index: 12

Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection

Journal of addictive diseases

2023/7/3

Olav Dalgard
Olav Dalgard

H-Index: 28

Brian Conway
Brian Conway

H-Index: 10

Patient reported outcomes during and following HCV direct-acting antiviral treatment among people who inject drugs

Value in Health

2023/6/1

Janaki Amin
Janaki Amin

H-Index: 36

Olav Dalgard
Olav Dalgard

H-Index: 28

Brian Conway
Brian Conway

H-Index: 10

The Nuc-Stop study: An open-label, randomized trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B patients

J. Hepatol

2023/6/1

Soo Aleman
Soo Aleman

H-Index: 20

Olav Dalgard
Olav Dalgard

H-Index: 28

Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study

Liver International

2020/10

Greg Kirk
Greg Kirk

H-Index: 3

Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines

Scientific Reports

2023/12/18

Olav Dalgard
Olav Dalgard

H-Index: 28

Dan Sun
Dan Sun

H-Index: 5

Niklas K Björkström
Niklas K Björkström

H-Index: 34

Patient-reported outcomes during and after hepatitis C virus direct-acting antiviral treatment among people who inject drugs

Value in Health

2023/6/1

Janaki Amin
Janaki Amin

H-Index: 36

Olav Dalgard
Olav Dalgard

H-Index: 28

Brian Conway
Brian Conway

H-Index: 10

Patrick Schmid
Patrick Schmid

H-Index: 1

David Shaw
David Shaw

H-Index: 24

John Dillon
John Dillon

H-Index: 41

Kate Mason
Kate Mason

H-Index: 16

Catherine Ferguson
Catherine Ferguson

H-Index: 5

Hiral Patel
Hiral Patel

H-Index: 2

Jonathan Anderson
Jonathan Anderson

H-Index: 2

High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway

Scandinavian Journal of Gastroenterology

2023/3/4

Yngve Mikkelsen
Yngve Mikkelsen

H-Index: 0

Ravinder Singh
Ravinder Singh

H-Index: 2

Martin Lagging
Martin Lagging

H-Index: 21

Olav Dalgard
Olav Dalgard

H-Index: 28

Corrigendum to ‘EASL recommendations on treatment of hepatitis C: Final update of the series’[J Hepatol 73 (2020) 1170–1218]

Journal of Hepatology

2023/2/1

Joint statement in support of hepatitis C human challenge studies

The Lancet Gastroenterology & Hepatology

2023/11/1

Eleanor Barnes
Eleanor Barnes

H-Index: 44

Charles Weijer
Charles Weijer

H-Index: 25

Mohammad Ali
Mohammad Ali

H-Index: 14

Yasemin Balaban
Yasemin Balaban

H-Index: 9

Ralf Bartenschlager
Ralf Bartenschlager

H-Index: 69

Paolo Bonanni
Paolo Bonanni

H-Index: 29

Graham Cooke
Graham Cooke

H-Index: 44

Olav Dalgard
Olav Dalgard

H-Index: 28

Nir Eyal
Nir Eyal

H-Index: 19

Kyle Ferguson
Kyle Ferguson

H-Index: 5

Meital Gal-Tanamy
Meital Gal-Tanamy

H-Index: 9

Jacob George
Jacob George

H-Index: 21

Richard Holton
Richard Holton

H-Index: 19

Georg Lauer
Georg Lauer

H-Index: 34

Lin Liu
Lin Liu

H-Index: 6

Volker Lohmann
Volker Lohmann

H-Index: 42

Joshua Morrison
Joshua Morrison

H-Index: 2

Francesco Negro
Francesco Negro

H-Index: 6

Kimberly Page
Kimberly Page

H-Index: 34

Steven Pinker
Steven Pinker

H-Index: 63

Nadine Rouphael
Nadine Rouphael

H-Index: 28

Chris Somerville
Chris Somerville

H-Index: 61

Kawsar Talaat
Kawsar Talaat

H-Index: 15

Larry Temkin
Larry Temkin

H-Index: 12

Norah Terrault
Norah Terrault

H-Index: 58

Chloe Thio
Chloe Thio

H-Index: 33

Alec Walen
Alec Walen

H-Index: 8

Christopher M Walker
Christopher M Walker

H-Index: 14

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Critical care

2023/1/10

Zoltán Péterfi
Zoltán Péterfi

H-Index: 7

Sotirios Tsiodras
Sotirios Tsiodras

H-Index: 35

Martin Schlegel
Martin Schlegel

H-Index: 16

Olav Dalgard
Olav Dalgard

H-Index: 28

Bente Halvorsen
Bente Halvorsen

H-Index: 32

See List of Professors in Olav Dalgard University(Universitetet i Oslo)